Clinical application of ABR in noise in normal population and patients with moderate hearing loss

Clinical application of ABR in noise in normal population and patients with moderate hearing loss - ABR in noise

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031118

Enrollment

Registered

2018-03-01

Start date

2018-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sensorineural hearing loss

Interventions

Questionnaire, audiometry, self-recording audiometry, sound-field speech discrimination test, SISI, DPOAE, ABR in noise

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Normal hearing, <20dB 2. Idiopathic sudden hearing loss, healed 3. Meniere's disease 4. Acute low tone loss 5. Tinnitus w/o hearing loss 6. Hyperacusis w/o hearing loss 7. Patients with head and neck cancer undergoing chemotherapy with cisplatin.

Exclusion criteria

Exclusion criteria: 1. Patients with external/middle ear diseases. 2. Patients with hearing loss >40dB in any frequency. 3. Patients in poor general conditions. 4. Minors

Design outcomes

Primary

Measure	Time frame
1. To investigate the prevalence of cochlear synaptopathy in normal hearing population and patients with moderate hearing loss. 2. To establish normal value of wave V latency in ABR in noise.	—

Countries

Japan

Contacts

Public ContactTaro Fujikawa

Tokyo Medical and Dental University Otolaryngology

fujikawa.oto@tmd.ac.jp03-5803-5308

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026